Search details
1.
A Common Variant at the 14q32 Endometrial Cancer Risk Locus Activates AKT1 through YY1 Binding.
Am J Hum Genet
; 98(6): 1159-1169, 2016 06 02.
Article
in English
| MEDLINE | ID: mdl-27259051
2.
Blocking 17ß-hydroxysteroid dehydrogenase type 1 in endometrial cancer: a potential novel endocrine therapeutic approach.
J Pathol
; 244(2): 203-214, 2018 02.
Article
in English
| MEDLINE | ID: mdl-29144553
3.
White Blood Cell BRCA1 Promoter Methylation Status and Ovarian Cancer Risk.
Ann Intern Med
; 168(5): 326-334, 2018 03 06.
Article
in English
| MEDLINE | ID: mdl-29335712
4.
HER2 expression patterns in paired primary and metastatic endometrial cancer lesions.
Br J Cancer
; 118(3): 378-387, 2018 02 06.
Article
in English
| MEDLINE | ID: mdl-29169184
5.
Asparaginase-like protein 1 is an independent prognostic marker in primary endometrial cancer, and is frequently lost in metastatic lesions.
Gynecol Oncol
; 148(1): 197-203, 2018 01.
Article
in English
| MEDLINE | ID: mdl-29096882
6.
Added Value of Estrogen Receptor, Progesterone Receptor, and L1 Cell Adhesion Molecule Expression to Histology-Based Endometrial Carcinoma Recurrence Prediction Models: An ENITEC Collaboration Study.
Int J Gynecol Cancer
; 28(3): 514-523, 2018 03.
Article
in English
| MEDLINE | ID: mdl-29324536
7.
Somatic mutation profiles of clear cell endometrial tumors revealed by whole exome and targeted gene sequencing.
Cancer
; 123(17): 3261-3268, 2017 Sep 01.
Article
in English
| MEDLINE | ID: mdl-28485815
8.
Expression of L1CAM in curettage or high L1CAM level in preoperative blood samples predicts lymph node metastases and poor outcome in endometrial cancer patients.
Br J Cancer
; 117(6): 840-847, 2017 Sep 05.
Article
in English
| MEDLINE | ID: mdl-28751757
9.
Cerebellar degeneration-related proteins 2 and 2-like are present in ovarian cancer in patients with and without Yo antibodies.
Cancer Immunol Immunother
; 66(11): 1463-1471, 2017 Nov.
Article
in English
| MEDLINE | ID: mdl-28710511
10.
MDM2 promoter polymorphism del1518 (rs3730485) and its impact on endometrial and ovarian cancer risk.
BMC Cancer
; 17(1): 97, 2017 02 03.
Article
in English
| MEDLINE | ID: mdl-28158999
11.
Expression of glucocorticoid receptor is associated with aggressive primary endometrial cancer and increases from primary to metastatic lesions.
Gynecol Oncol
; 147(3): 672-677, 2017 12.
Article
in English
| MEDLINE | ID: mdl-28927900
12.
Clinicopathologic and molecular markers in cervical carcinoma: a prospective cohort study.
Am J Obstet Gynecol
; 217(4): 432.e1-432.e17, 2017 10.
Article
in English
| MEDLINE | ID: mdl-28599900
13.
A national, prospective observational study of first recurrence after primary treatment for gynecological cancer in Norway.
Acta Obstet Gynecol Scand
; 96(10): 1162-1169, 2017 Oct.
Article
in English
| MEDLINE | ID: mdl-28795770
14.
L1CAM expression in endometrial carcinomas: an ENITEC collaboration study.
Br J Cancer
; 115(6): 716-24, 2016 Sep 06.
Article
in English
| MEDLINE | ID: mdl-27505134
15.
The MDM4 SNP34091 (rs4245739) C-allele is associated with increased risk of ovarian-but not endometrial cancer.
Tumour Biol
; 37(8): 10697-702, 2016 Aug.
Article
in English
| MEDLINE | ID: mdl-26867771
16.
What Is the Best Preoperative Imaging for Endometrial Cancer?
Curr Oncol Rep
; 18(4): 25, 2016 Apr.
Article
in English
| MEDLINE | ID: mdl-26922331
17.
Candidate locus analysis of the TERT-CLPTM1L cancer risk region on chromosome 5p15 identifies multiple independent variants associated with endometrial cancer risk.
Hum Genet
; 134(2): 231-45, 2015 Feb.
Article
in English
| MEDLINE | ID: mdl-25487306
18.
Distribution volumes of macromolecules in human ovarian and endometrial cancers--effects of extracellular matrix structure.
Am J Physiol Heart Circ Physiol
; 308(1): H18-28, 2015 Jan 01.
Article
in English
| MEDLINE | ID: mdl-25380817
19.
Loss of ASRGL1 expression is an independent biomarker for disease-specific survival in endometrioid endometrial carcinoma.
Gynecol Oncol
; 137(3): 529-37, 2015 Jun.
Article
in English
| MEDLINE | ID: mdl-25858696
20.
Preoperative tumor size at MRI predicts deep myometrial invasion, lymph node metastases, and patient outcome in endometrial carcinomas.
Int J Gynecol Cancer
; 25(3): 459-66, 2015 Mar.
Article
in English
| MEDLINE | ID: mdl-25628109